Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

76.15p
   
  • Change Today:
    -1.15p
  • 52 Week High: 99.35
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 967.08m
  • Volume: 119,780
  • Market Cap: £736.43m

Dr Martens plans price rises to offset US tariffs, shares slump

By Frank Prenesti

Date: Thursday 20 Nov 2025

LONDON (ShareCast) - (Sharecast News) - Shares in Dr Martens slumped on Thursday as the British bootmaker said it would take a multi-million pound hit from US tariffs, forcing it to raise prices in a key market.


The company said it expected tariffs to be in the high single-digit million-pound range but would be offsetting roughly half of this impact through price hikes. It had previously pledged to keep prices on hold this year but now needed to make increases from the start of 2026 on "selected products" in the US only.

Production of footwear for the US market is also being shifted from Laos to Vietnam where the tariff rate of 20% is half that levied on its neighbour.

Adjusted pre-tax losses came in at £9.2m for the six-months to September 28, compared with £16.6m last year. Americas was the best performing region with revenue up 6% with both the direct-to-consumer and wholesale channels in positive growth.

Despite the improved performance, shares in the firm were down 10% in early London trade amid a rising market.

Sales rose 0.8% on a constant currency basis to £327.3m.

The company, famed for its lace-up boots with chunky soles, said it was expecting adjusted profits in a £53m to £60m range, according to consensus forecasts and excluding the impact from tariffs.

"While the trading backdrop across our markets remains volatile, we are focused on executing our plans, growing profit and taking the right decisions for full-year 2027 and beyond," the company said on Thursday.

"Since the end of the first half, our Americas business has continued to deliver positive full price DTC growth. Our EMEA business continues to see variable trading and a particularly challenging performance in retail across our largest markets."

AJ Bell investment director Russ Mould said there were "some glimmers of hope" in the results but the market "is not blown away by the figures, and a falling share price in early trading indicates investor disappointment".

"Dr Martens is taking baby steps to put the business on a profitable path. Its turnaround efforts are underway, but this could be a slow recovery rather than a giant leap back to normality."

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 76.15p
Change Today -1.15p
% Change -1.49 %
52 Week High 99.35
52 Week Low 47.52
Volume 119,780
Shares Issued 967.08m
Market Cap £736.43m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 28-Aug-25
Paid 09-Apr-26 08-Oct-25
Amount 0.85p 1.70p

Trades for 01-Dec-2025

Time Volume / Share Price
12:18 3,157 @ 76.25p
12:10 700 @ 76.15p
12:10 118 @ 76.15p
12:10 112 @ 76.15p
12:10 136 @ 76.15p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page